Mesenchymal stem cells as a novel vaccine platform.
Saved in:
| Title: | Mesenchymal stem cells as a novel vaccine platform. |
|---|---|
| Authors: | Tomchuck SL; Department of Microbiology and Immunology, Tulane University School of Medicine New Orleans, LA, USA., Norton EB, Garry RF, Bunnell BA, Morris CA, Freytag LC, Clements JD |
| Source: | Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2012 Nov 16; Vol. 2, pp. 140. Date of Electronic Publication: 2012 Nov 16 (Print Publication: 2012). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 23162801 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Mesenchymal stem cells as a novel vaccine platform. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tomchuck+SL%22">Tomchuck SL</searchLink>; Department of Microbiology and Immunology, Tulane University School of Medicine New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Norton+EB%22">Norton EB</searchLink><br /><searchLink fieldCode="AU" term="%22Garry+RF%22">Garry RF</searchLink><br /><searchLink fieldCode="AU" term="%22Bunnell+BA%22">Bunnell BA</searchLink><br /><searchLink fieldCode="AU" term="%22Morris+CA%22">Morris CA</searchLink><br /><searchLink fieldCode="AU" term="%22Freytag+LC%22">Freytag LC</searchLink><br /><searchLink fieldCode="AU" term="%22Clements+JD%22">Clements JD</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101585359%22">Frontiers in cellular and infection microbiology</searchLink> [Front Cell Infect Microbiol] 2012 Nov 16; Vol. 2, pp. 140. <i>Date of Electronic Publication: </i>2012 Nov 16 (<i>Print Publication: </i>2012). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+SA%22">Frontiers Media SA </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101585359 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2235-2988 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222352988%22">22352988 </searchLink><i>NLM ISO Abbreviation: </i>Front Cell Infect Microbiol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=23162801 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fcimb.2012.00140 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 140 Titles: – TitleFull: Mesenchymal stem cells as a novel vaccine platform. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tomchuck SL – PersonEntity: Name: NameFull: Norton EB – PersonEntity: Name: NameFull: Garry RF – PersonEntity: Name: NameFull: Bunnell BA – PersonEntity: Name: NameFull: Morris CA – PersonEntity: Name: NameFull: Freytag LC – PersonEntity: Name: NameFull: Clements JD IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 11 Text: 2012 Nov 16 Type: published Y: 2012 Identifiers: – Type: issn-electronic Value: 2235-2988 Numbering: – Type: volume Value: 2 Titles: – TitleFull: Frontiers in cellular and infection microbiology Type: main |
| ResultId | 1 |
